Particle.news
Download on the App Store
6 ARTICLES
·
9h ago

Greggs Ties Menu Shift to Weight-Loss Drugs, Reports Q4 Sales Growth

Shifting demand toward smaller, higher‑protein choices prompts new items, with guidance remaining cautious.

A sign is displayed near a Sainsbury's Local store in London, Britain, January 2, 2025. REUTERS/Hollie Adams
Image
Image
An employee holds a tray of freshly baked sausage rolls in a Greggs Plc sandwich chain outlet in Caterham, U.K., on Thursday, Oct. 22, 2015. Same-store sales at Greggs have grown 5.6 percent so far in 2015, up from 3.9 percent across the same period last year, and the company said on Oct. 6 that full-year growth will exceed its previous forecast slightly. Photographer: Chris Ratcliffe/Bloomberg via Getty Images

Overview

  • Chief executive Roisin Currie said there is "no doubt" GLP‑1 appetite suppressants are influencing customer behavior and menu planning.
  • Total sales rose 7.4% in the three months to December 27, while full‑year like‑for‑like sales increased 2.4%, below 2024’s pace.
  • Greggs has sold about 500,000 egg pots since autumn and this week launched overnight oats; hot snacks still average 1.3 million weekly sales.
  • Currie noted the shift also reflects a broader health trend as customers look for smaller portions and clearer protein and fiber information.
  • Tesco flagged "GLP‑1 friendly" ranges and close monitoring of shopper behavior, and M&S introduced a nutrient‑dense line in late December, while Greggs set a "cautious but hopeful" 2026 outlook.